Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
200 participants
INTERVENTIONAL
2022-01-01
2024-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
TIP Repair of Distal Penile Hypospadias Using Rapidly Absorbable Braided Vs Slowly Absorbable Monofilament Sutures
NCT06413901
Modified TIP (Snodgrass) Using Interrupted Sutures in Hypospadias
NCT06180018
Insitu Repair Versus Uterine Exeriorization During Cesarean Section
NCT01723605
Thulium Beam Coagulation Versus Suture Renorrhaphy for Hemostasis of Tumor Bed in Laparoscopic Partial Nephrectomy
NCT06322745
PRP Gel in Wound Closure in Recurrent CS
NCT02775747
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Although many surgical modifications and techniques have been prescribed to minimize post-operative complications and improve outcomes, a high percentage of complications still occurs. Urethrocutaneous fistulae are the most common post-operative complication (10%-40%) after hypospadias surgery; other complications being skin flap related complications such as flap necrosis, suture line breakdown, ascent of the testis and penile torsion (Shenoy et al.,2021).
In this thesis a secondary preputial dartos flap will be performed in all cases and we will evaluate the value of usage of fibrin glue on the 1ry suture line .
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fibrin group
Fibrin sealant covered with 2ry dartos flap.
fibrin sealant in hypospadias
fibrin sealant will be used over the suture line
Standard TIP technique
standard TIP technique with second dartos flap and no use of fibrin sealant
fibrin sealant in hypospadias
fibrin sealant will be used over the suture line
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
fibrin sealant in hypospadias
fibrin sealant will be used over the suture line
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* Recurrent cases.
* Prio pelvic trauma or radiation.
3 Months
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Benha University
OTHER
Al-Azhar University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Fawzy Abd Elfattah Salman
Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Urology department - AlAzhar university
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Fibrin sealant in hypospadius
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.